PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2.86%
Net income growth under 50% of MCHP's 10.89%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.75%
D&A growth well above MCHP's 0.50%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
103.23%
Some yoy growth while MCHP is negative at -14.55%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
5.71%
SBC growth well above MCHP's 5.36%. Michael Burry would flag major dilution risk vs. competitor’s approach.
132.91%
Slight usage while MCHP is negative at -14.10%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
44.89%
AR growth well above MCHP's 67.45%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
40.21%
Some inventory rise while MCHP is negative at -205.38%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
111.76%
A yoy AP increase while MCHP is negative at -128.97%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
306.80%
Growth well above MCHP's 355.71%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
17.65%
Some yoy increase while MCHP is negative at -26.70%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
64.21%
Operating cash flow growth above 1.5x MCHP's 1.49%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-31.75%
Both yoy lines negative, with MCHP at -170.65%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-21.79%
Negative yoy purchasing while MCHP stands at 19.58%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-5.50%
We reduce yoy sales while MCHP is 130.08%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-5975.00%
Both yoy lines negative, with MCHP at -346.52%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-130.45%
We reduce yoy invests while MCHP stands at 48.71%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-42.70%
Negative yoy issuance while MCHP is 237.51%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-16.61%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.